Eton Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Eton Pharmaceuticals

12/11/2024 23:16

* Eton Pharmaceuticals Inc  ETON.OQ  reported quarterly
adjusted
earnings of 3 cents​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of -2 cents.  The mean expectation of two analysts
for the quarter was for a loss of one cent per share. 
    * Revenue rose 46.9% to $10.32 million from a year ago;
analysts
expected $9.70 million. 
    * Eton Pharmaceuticals Inc's reported EPS for the quarter
was 2
cents​.
    * The company reported quarterly net income of $627
thousand.
    * Eton Pharmaceuticals Inc shares had risen by 61.8% this
quarter and gained 121.7% so far this year.

FORECAST CHANGES
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Eton
Pharmaceuticals Inc is $13.00 
This summary was machine generated from LSEG data November 12 at
11:16 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.01          0.03           Beat
 Jun. 30 2024      -0.07          -0.12          Missed
 Mar. 31 2024      -0.04          -0.03          Beat
 Dec. 31 2023      -0.04          -0.09          Missed